Evidence map›Paper›PMID 35084981›Full record

ArticleScience (New York, N.Y.)2022

Amplification of human interneuron progenitors promotes brain tumors and neurological defects.

Oliver L Eichmüller, Nina S Corsini, Ábel Vértesy, Ilaria Morassut, Theresa Scholl, Victoria-Elisabeth Gruber, Angela M Peer, Julia Chu, Maria Novatchkova, Johannes A Hainfellner and 3 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 4 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 4 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Tuberous sclerosis complex.Nature reviews. Disease primers · 2026
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Oliver L EichmüllerInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-1077-403X
Nina S CorsiniInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0001-6731-3544
Ábel VértesyInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0001-6075-5702
Ilaria MorassutInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.
Theresa SchollDepartment of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9835-7328
Victoria-Elisabeth GruberDepartment of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6153-9291
Angela M PeerInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.
Julia ChuDepartment of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Maria NovatchkovaInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.
Johannes A HainfellnerDepartment of Neurology, Medical University of Vienna, Vienna, Austria.
Mercedes F ParedesDepartment of Neurology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-2503-1447
Martha FeuchtDepartment of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Jürgen A KnoblichInstitute of Molecular Biotechnology (IMBA), Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-6751-3404
Institute of Molecular Biotechnology · ATMedical University of Vienna · ATUniversity of California, San Francisco · US

Funding

Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Regulation of Cellular Pathwaysin Human Brain DevelopmentP01NS083513 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRIEGSTEIN, ARNOLD · 2014 to 2024
$12.6M
Gyrencephalic Model for Neurodevelopmental Disease and Postnatal Cortical Therapeutic InterventionsDP2NS122550 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PAREDES, MERCEDES · 2020 to 2020
$2.4M
Austrian Science Fund FWF F 7804European Research Council 695642NCI NIH HHS P50 CA097257NINDS NIH HHS DP2 NS122550NINDS NIH HHS P01 NS083513
6 · The paper itself

Abstract

Evolutionary development of the human brain is characterized by the expansion of various brain regions. Here, we show that developmental processes specific to humans are responsible for malformations of cortical development (MCDs), which result in developmental delay and epilepsy in children. We generated a human cerebral organoid model for tuberous sclerosis complex (TSC) and identified a specific neural stem cell type, caudal late interneuron progenitor (CLIP) cells. In TSC, CLIP cells over-proliferate, generating excessive interneurons, brain tumors, and cortical malformations. Epidermal growth factor receptor inhibition reduces tumor burden, identifying potential treatment options for TSC and related disorders. The identification of CLIP cells reveals the extended interneuron generation in the human brain as a vulnerability for disease. In addition, this work demonstrates that analyzing MCDs can reveal fundamental insights into human-specific aspects of brain development.

Indexed as

BrainBrain NeoplasmsCarcinogenesisCell LineageCell ProliferationDisease ProgressionErbB ReceptorsGene Expression ProfilingHumansInduced Pluripotent Stem CellsInterneuronsLoss of HeterozygosityNeural Stem CellsOrganoidsRNA-SeqTOR Serine-Threonine KinasesEGFR protein, humanErbB ReceptorsMTOR protein, humanTOR Serine-Threonine KinasesTSC1 protein, humanTSC2 protein, humanTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 Protein

Identifiers

PMID35084981
PMCPMC7613689
OpenAlexW4210452888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.